FRS2 Monoklonaler Antikörper
FRS2 Monoklonal Antikörper für WB, IHC, IF/ICC, Indirect ELISA
Wirt / Isotyp
Maus / IgG3
Getestete Reaktivität
human
Anwendung
WB, IHC, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
4E10H12
Kat-Nr. : 66263-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
66263-1-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA FRS2 und zeigt Reaktivität mit human
Getestete Reaktivität | human |
Wirt / Isotyp | Maus / IgG3 |
Klonalität | Monoklonal |
Typ | Antikörper |
Immunogen | FRS2 fusion protein Ag19299 |
Vollständiger Name | fibroblast growth factor receptor substrate 2 |
Berechnetes Molekulargewicht | 60 kDa |
Beobachtetes Molekulargewicht | 68 kDa |
GenBank-Zugangsnummer | BC021562 |
Gene symbol | FRS2 |
Gene ID (NCBI) | 10818 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein-A-Reinigung |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Fibroblast growth factor (FGF) receptor substrate 2 (FRS2) has an alternative name as SNT-1, it is an adapter protein that links activated FGR and NGF receptors to downstream signaling pathways. FGF receptor substrates (FRS2 and FRS3) are key adaptor proteins that mediate FGF-FGFR signalling in benign as well as malignant tissue. FRS2 is a 508 amino-acid protein,which is phosphorylated on tyrosine residues. The molecular weight of non-phosphorylated FRS2 is 57-68 kDa, but phosphorylated FRS2 is 80-90 kDa. Phosphorylation of FRS2 is associated with activation of a number of MAP kinases. Allele-specific regulation of FGFR2 mRNA expression with a mildly increased breast cancer risk has been reported.